Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHUMHumana$249.32-0.4%$271.59$213.31▼$406.46$30.08B0.571.67 million shs1.15 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHUMHumana-0.48%-5.13%-8.70%-10.01%-27.90%Remove AdsMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHUMHumana4.5821 of 5 stars3.15.02.53.93.32.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHUMHumana 2.21Hold$285.6814.59% UpsideCurrent Analyst Ratings BreakdownLatest HUM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/18/2025HUMHumanaJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$257.00 ➝ $256.002/13/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$255.00 ➝ $270.002/12/2025HUMHumanaRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$283.00 ➝ $283.002/12/2025HUMHumanaCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$290.00 ➝ $290.002/12/2025HUMHumanaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$301.00 ➝ $285.001/22/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$253.00 ➝ $255.001/15/2025HUMHumanaPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$270.00 ➝ $288.001/6/2025HUMHumanaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$260.00 ➝ $290.0012/17/2024HUMHumanaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$288.00 ➝ $301.00(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHUMHumana$117.76B0.26$21.93 per share11.37$136.57 per share1.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHUMHumana$1.21B$9.9525.0618.992.051.02%11.70%3.99%4/23/2025 (Estimated)Latest HUM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/11/2025Q4 2024HUMHumana-$2.26-$2.16+$0.10-$5.76$28.84 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHUMHumana$3.541.42%+8.13%35.58%N/ALatest HUM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/20/2025HUMHumanaquarterly$0.88501.33%3/28/20253/28/20254/25/2025(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHUMHumana0.681.761.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHUMHumana92.38%Insider OwnershipCompanyInsider OwnershipHUMHumana0.32%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHUMHumana67,100120.65 million120.03 millionOptionableHUM HeadlinesRecent News About These Companies1.4-Million-Year-Old Skull Fragments Linked to Mystery Human AncestorMarch 12 at 10:16 PM | gizmodo.comRiver Road Asset Management LLC Takes $3.47 Million Position in Humana Inc. (NYSE:HUM)March 12 at 5:22 AM | marketbeat.comHumana to invest $20 million in Waterside Building renovationsMarch 11 at 9:11 PM | msn.comHumana making $21M+ in renovations to new downtown Louisville HQ amid consolidationMarch 11 at 4:11 PM | msn.comHumana to renovate new headquarters at Waterside Building in downtown LouisvilleMarch 11 at 7:30 AM | wdrb.comHumana Inc. (NYSE:HUM) is Pzena Investment Management LLC's 9th Largest PositionMarch 11 at 5:53 AM | marketbeat.comHumana Inc. (NYSE:HUM) Shares Sold by S&CO Inc.March 11 at 5:44 AM | marketbeat.com4,580 Shares in Humana Inc. (NYSE:HUM) Acquired by Marathon Trading Investment Management LLCMarch 11 at 5:35 AM | marketbeat.comAmundi Trims Stock Position in Humana Inc. (NYSE:HUM)March 11 at 4:29 AM | marketbeat.comHumana Inc. (NYSE:HUM) Shares Sold by PNC Financial Services Group Inc.March 11 at 4:21 AM | marketbeat.comSOS: SSM Health billing problem sparks familiar feeling in Fitchburg womanMarch 10 at 8:50 AM | madison.comM&T Bank Corp Reduces Holdings in Humana Inc. (NYSE:HUM)March 10 at 3:56 AM | marketbeat.comAssetmark Inc. Sells 2,609 Shares of Humana Inc. (NYSE:HUM)March 10 at 3:56 AM | marketbeat.comIs Humana Inc. (HUM) the Top Health Insurance Stock to Buy Now?March 9 at 9:36 PM | msn.comAMF Tjanstepension AB Reduces Stock Holdings in Humana Inc. (NYSE:HUM)March 9 at 6:16 AM | marketbeat.comDavis Selected Advisers Lowers Position in Humana Inc. (NYSE:HUM)March 9 at 6:10 AM | marketbeat.comHumana Inc. (NYSE:HUM) Shares Sold by Andra AP fondenMarch 9 at 5:52 AM | marketbeat.comEdgestream Partners L.P. Grows Stock Position in Humana Inc. (NYSE:HUM)March 9 at 5:45 AM | marketbeat.comAMG National Trust Bank Purchases New Shares in Humana Inc. (NYSE:HUM)March 9 at 5:35 AM | marketbeat.comCullen Frost Bankers Inc. Decreases Holdings in Humana Inc. (NYSE:HUM)March 9 at 5:11 AM | marketbeat.comVictory Capital Management Inc. Purchases 78,351 Shares of Humana Inc. (NYSE:HUM)March 9 at 4:51 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPrice Targets on NVIDIA Rise in Front of EarningsBy Sarah Horvath | February 24, 2025View Price Targets on NVIDIA Rise in Front of EarningsWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Hidden AI Play: The Truth Behind Its WeRide InvestmentBy Gabriel Osorio-Mazilli | February 14, 2025View NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide InvestmentArcher Aviation Stock Skids: Mistaking Progress for Bad News?By Chris Markoch | February 24, 2025View Archer Aviation Stock Skids: Mistaking Progress for Bad News?Humana Gains Despite Medicare Advantage Losses—What’s the Catch?By Jea Yu | February 20, 2025View Humana Gains Despite Medicare Advantage Losses—What’s the Catch?HUM Company DescriptionsHumana NYSE:HUM$249.32 -0.88 (-0.35%) Closing price 03:58 PM EasternExtended Trading$253.50 +4.19 (+1.68%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ramaco Resources Pins Hopes on Coal's Untapped Potential Beyond a Market Correction, Moves to Make Now NVIDIA Stock Remains Stunningly Undervalued—Here’s Why Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy 3 Stocks Institutions Are Quietly Dumping Marvell’s 40% Drop Presents a Compelling Buying Opportunity These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Why Wayfair Stock May Be a Hidden Gem for Value Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
